Home > Journals > Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring Impact Factor, Indexing, Ranking
Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring (ADDADM) is a scholarly journal dedicated to publishing research in the field of Medicine. John Wiley and Sons is the publisher of this esteemed journal. and its abbreviated form is Alzheimers Dement (Amst).
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access journal that concentrates on the discovery, development, and validation of assays, instruments, and technologies with the potential to facilitate accurate detection of dementia in its various forms and stages. Of particular interest are promising dementia biomarkers, ranging from gene expression and proteomic markers, to imaging, cognitive and functional markers of disease progression or treatment response. Review our Author Guidelines and submit your manuscript to DADM.
Journal title | Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring (ADDADM) |
Abbreviation | Alzheimers Dement (Amst) |
Online ISSN | 2352-8729 |
Publisher Name | John Wiley and Sons |
Editor-in-chief | Liana G. Apostolova |
Subject Category | Medicine |
Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring Journal is Alzheimers Dement (Amst).
The Ranking of the Journal in 2024 is 1509. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 5.3. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 1.847. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Acceptance Rate in 2024 is 51%. It is a measure that provides insight into the selectivity and competitiveness of a journal's editorial process.
The Journal's H-Index in 2024 is 53. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Journal is indexed in (Indexing details)
PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
---|---|---|---|---|---|
✅ | ✅ | ✅ | ✅ | ❌ | ✅ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Abbreviation | Alzheimers Dement (Amst) |
Access type | Open Access |
Acceptance rate | 51% |
Impact Factor | 5.3 |
SJR | 1.847 |
SNIP | 1.311 |
Ranking | 1509 |
CiteScore | 8.4 |
H-Index | 53 |
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is For Non Member $2,310 USD / £1,680 GBP / €1,890 EUR, For Member $1,155 USD / £840 GBP / €945 EUR
Call for paper : The Journal invites original research contributions for consideration of publication in Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring journal.
Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring involves the following steps:
Yes, the journal is indexed in PubMed.
Yes, the journal is indexed in Scopus.
Yes, the journal is indexed in UGC.
No, the journal is not indexed in Index copernicus.
No, journal is not a predatory journal.
The Impact Factor of the Journal is 5.3.
The Ranking of the Journal is 1509.
Yes the journal is a peer-reviewed journal.
Yes the journal is a peer-reviewed journal and good to publish your paper.
Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring (ADDADM) is a scholarly journal dedicated to publishing research in the field of Medicine. John Wiley and Sons is the publisher of this esteemed journal.
Yes, Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring is a open access journal.